Business

Eli Lilly's Weight-Loss Drug Trial Boosts Stock

Updated 2026-06-08 10:30 UTC 1 source Positive

Eli Lilly’s stock surged in premarket trading after positive results from a late-stage trial of its next-generation weight-loss drug. Analysts praised the outcome, which could accelerate regulatory approval and boost sales.

Coverage timeline — 1 article

MarketWatch

Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug

Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.

2026-06-08 10:16 UTC